anmelden
FTSE All-Share
5.850,42
PKT
+17,79
PKT
+0,31
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 03.03.16 | Glencore Outperform | BNP PARIBAS | |
| 03.03.16 | Glencore buy | UBS AG | |
| 02.03.16 | Barclays kaufen | Independent Research GmbH | |
| 02.03.16 | BT Group Neutral | Citigroup Corp. | |
| 02.03.16 | BT Group Sell | Deutsche Bank AG | |
| 02.03.16 | Barclays Conviction Buy | Goldman Sachs Group Inc. | |
| 02.03.16 | Glencore buy | Citigroup Corp. | |
| 02.03.16 | Glencore Outperform | Credit Suisse Group | |
| 02.03.16 | Barclays Equal-Weight | Morgan Stanley | |
| 02.03.16 | Glencore buy | Deutsche Bank AG | |
| 02.03.16 | Barclays overweight | JP Morgan Chase & Co. | |
| 02.03.16 | Barclays buy | Société Générale Group S.A. (SG) | |
| 02.03.16 | Barclays buy | UBS AG | |
| 01.03.16 | Barclays buy | Citigroup Corp. | |
| 01.03.16 | Barclays buy | Nomura | |
| 01.03.16 | Shell (ex Royal Dutch Shell) overweight | Barclays Capital | |
| 01.03.16 | BP overweight | Barclays Capital | |
| 01.03.16 | BAT buy | Nomura | |
| 01.03.16 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
| 29.02.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 29.02.16 | Sky buy | Goldman Sachs Group Inc. | |
| 29.02.16 | HSBC Underperform | Bernstein Research | |
| 26.02.16 | BAT Neutral | BNP PARIBAS | |
| 26.02.16 | AstraZeneca Outperform | BNP PARIBAS | |
| 26.02.16 | BAT Equal-Weight | Morgan Stanley | |
| 26.02.16 | Lloyds Banking Group buy | UBS AG | |
| 26.02.16 | BAT buy | Société Générale Group S.A. (SG) | |
| 26.02.16 | BAT overweight | Barclays Capital | |
| 26.02.16 | Standard Chartered buy | Goldman Sachs Group Inc. | |
| 25.02.16 | HSBC buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.02.16 | Standard Chartered Halten | Independent Research GmbH | |
| 25.02.16 | HSBC Equal weight | Barclays Capital | |
| 25.02.16 | Standard Chartered verkaufen | BNP PARIBAS | |
| 25.02.16 | Standard Chartered Neutral | UBS AG | |
| 25.02.16 | Imperial Brands Reduce | Nomura | |
| 24.02.16 | Lloyds Banking Group Neutral | Macquarie Research | |
| 24.02.16 | Barclays Outperform | Macquarie Research | |
| 24.02.16 | Vodafone Group kaufen | Morgan Stanley | |
| 24.02.16 | GSK Neutral | UBS AG | |
| 24.02.16 | London Stock Exchange (LSE) Outperform | Credit Suisse Group |
